Nina Tracy, | |
7945 Macarthur Blvd Ste 214, Cabin John, MD 20818-1634 | |
(301) 987-7284 | |
Not Available |
Full Name | Nina Tracy |
---|---|
Gender | Female |
Speciality | Marriage & Family Therapist |
Location | 7945 Macarthur Blvd Ste 214, Cabin John, Maryland |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1023358355 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
106H00000X | Marriage & Family Therapist | (* (Not Available)) | Primary |
Mailing Address | Practice Location Address |
---|---|
Nina Tracy, 10111 Frederick Ave, Kensington, MD 20895-3404 Ph: () - | Nina Tracy, 7945 Macarthur Blvd Ste 214, Cabin John, MD 20818-1634 Ph: (301) 987-7284 |
News Archive
A report by neurosurgeons at the Papa Giovanni XXIII Hospital in Bergamo, Italy, highlights the strategies their unit had to take to help combat the viral illness, which has claimed the lives of more than 1.49 million people worldwide. The study was published in the Journal of Neurosurgery in December 2020.
Intra-Cellular Therapies, Inc. (ITI) announced at a recent conference on neuropsychiatric diseases the results from a recently completed Phase I clinical study demonstrating ITI-007, the Company's lead antipsychotic drug, interacts with important targets in the living human brain. These key targets are critical to drug action in many neuropsychiatric and related disorders.
Recently published research shows that coffee drinkers enjoy not only the taste of their coffee but also a reduced risk of cancer with their cuppa. More detailed research published today in BioMed Central's open access journal Breast Cancer Research shows that drinking coffee specifically reduces the risk of antiestrogen-resistant estrogen-receptor-negative breast cancer.
Genomatix Software, the Uniformed Service University of the Health Sciences (USU), and the Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. (HJF) have entered into a Cooperative Research and Development Agreement (CRADA) to extend their collaborative endeavors in prostate disease research.
› Verified 9 days ago